Capillary Technologies India Ltd (CAPILLARY) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- The company reported a strong start to the fiscal year, driven by a dual-engine growth strategy of organic expansion and successful inorganic integrations, leading to significant year-on-year growth in both revenue and profitability.
- Organic business demonstrated robust health with a 17% YoY growth and an adjusted EBITDA margin of over 20%, underscoring the core platform's strength and efficiency.
- The integration of the SessionM acquisition is proceeding as planned, with the business turning profitable within the first two months and showing strong potential for future NRR growth through cross-selling opportunities.
- The company's AI platform, Ira, is gaining significant traction, acting as a key differentiator in new deals and is expected to contribute 5-10% of total revenue this fiscal year, reflecting a successful shift towards a system of intelligence.
- Margin expansion was a key theme, with adjusted EBITDA margins improving from 10% to 18% YoY, primarily due to higher-margin NRR expansion, operating leverage on non-COGS costs, and successful migration of customers from prior acquisitions to the more efficient Capillary platform.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.